Neutral low-dimensional assemblies of a Mn(III) schiff base complex and octacyanotungstate(V) : synthesis, characterization, and magnetic properties

International audienceTwo novel low-dimensional molecular magnetic materials were prepared by the self-assembly of 3d- and 5d-metal complexes. These are the first neutral heterobimetallic cyanobridged compounds involving one anisotropic Mn(III) Schiff base complex and one octacyanotungstate(V) per molecular unit. A slow diffusion of the constituents’ solutions leads to the formation of the 0D crystalline complex 1, due to coordination of a water molecule to the Mn center, which prevents polymer formation. A rapid mixing of reagents results in the precipitation of the microcrystalline powder of complex 2, which based on the totality of experimental data, possesses a 1D polymeric structure. The magnetic studies have shown that antiferromagnetic exchange interactions prevail in 1 (J/kB = −13.1(7) K, D = −3.0(1.3) K, zJ' = −0.16(20) K and gav = 2.00(1)); while the presence of the significant intramolecular Mn(III)–W(V) ferromagnetic coupling through cyanide bridge is characteristic for 2 (J/kB = 46.1(5) K, gMn = 2.11(3), fixed gW = 2.0). Due to the weak interchain interactions, zJ′/kB = −0.8(2) K, and compound 2 is a metamagnet with the Néel temperature of 9.5 K undergoing a spin-flip transition at 2 kOe. The slow magnetization dynamics of 2 were investigated at a DC field of 0 and 2 kOe, giving the values of τ0 32(15) and 36(15) ps, respectively, well within the range typical for single-chain magnets (SCMs). The respective ∆τ/kB values were 48.4(1.2) and 44.9(1.0) K

An efficient MPI/OpenMP parallelization of the Hartree-Fock method for the second generation of Intel Xeon Phi processor

Modern OpenMP threading techniques are used to convert the MPI-only Hartree-Fock code in the GAMESS program to a hybrid MPI/OpenMP algorithm. Two separate implementations that differ by the sharing or replication of key data structures among threads are considered, density and Fock matrices. All implementations are benchmarked on a super-computer of 3,000 Intel Xeon Phi processors. With 64 cores per processor, scaling numbers are reported on up to 192,000 cores. The hybrid MPI/OpenMP implementation reduces the memory footprint by approximately 200 times compared to the legacy code. The MPI/OpenMP code was shown to run up to six times faster than the original for a range of molecular system sizes.Comment: SC17 conference paper, 12 pages, 7 figure

Design, Fabrication, and Application of Mini-Scaffolds for Cell Component in Tissue Engineering

publishersversionPeer reviewe

Development of methods of phosphorylation of citral by medial and acidic phosphites

The reactions of trimethyl phosphite with citral in the presence of acetic acid, triphenyl phosphite with citral in the presence of water and trimethyl phosphite with citral in the presence of water and triethylamine in the methanol solution were studied. On the basis of these studies, dienyl 1-hydroxyphosphonates were obtained. A convenient method of synthesizing unsaturated 1-hydroxyphosphonates was developed on the basis of reaction of dialkyl phosphites with citral in the presence of triethylamine in molar ratio 4:2:8 in alcohol solutions

Structure- and interaction-based design of anti-SARS-CoV-2 aptamers

Aptamer selection against novel infections is a complicated and time-consuming approach. Synergy can be achieved by using computational methods together with experimental procedures. This study aims to develop a reliable methodology for a rational aptamer in silico et vitro design. The new approach combines multiple steps: (1) Molecular design, based on screening in a DNA aptamer library and directed mutagenesis to fit the protein tertiary structure; (2) 3D molecular modeling of the target; (3) Molecular docking of an aptamer with the protein; (4) Molecular dynamics (MD) simulations of the complexes; (5) Quantum-mechanical (QM) evaluation of the interactions between aptamer and target with further analysis; (6) Experimental verification at each cycle for structure and binding affinity by using small-angle X-ray scattering, cytometry, and fluorescence polarization. By using a new iterative design procedure, structure- and interaction-based drug design (SIBDD), a highly specific aptamer to the receptorbinding domain of the SARS-CoV-2 spike protein, was developed and validated. The SIBDD approach enhances speed of the high-affinity aptamers development from scratch, using a target protein structure. The method could be used to improve existing aptamers for stronger binding. This approach brings to an advanced level the development of novel affinity probes, functional nucleic acids. It offers a blueprint for the straightforward design of targeting molecules for new pathogen agents and emerging variant

Commercial articulated collaborative in situ 3D bioprinter for skin wound healing

In situ bioprinting is one of the most clinically relevant techniques in the emerging bioprinting technology because it could be performed directly on the human body in the operating room and it does not require bioreactors for post-printing tissue maturation. However, commercial in situ bioprinters are still not available on the market. In this study, we demonstrated the benefit of the originally developed first commercial articulated collaborative in situ bioprinter for the treatment of full-thickness wounds in rat and porcine models. We used an articulated and collaborative robotic arm from company KUKA and developed original printhead and correspondence software enabling in situ bioprinting on curve and moving surfaces. The results of in vitro and in vivo experiments show that in situ bioprinting of bioink induces a strong hydrogel adhesion and enables printing on curved surfaces of wet tissues with a high level of fidelity. The in situ bioprinter was convenient to use in the operating room. Additional in vitro experiments (in vitro collagen contraction assay and in vitro 3D angiogenesis assay) and histological analyses demonstrated that in situ bioprinting improves the quality of wound healing in rat and porcine skin wounds. The absence of interference with the normal process of wound healing and even certain improvement in the dynamics of this process strongly suggests that in situ bioprinting could be used as a novel therapeutic modality in wound healing.publishersversionPeer reviewe